Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease

Thomas C. Shea, Christine M. Walko, Yunro Chung, Anastasia Ivanova, Kamakshi V. Rao, James Coghill, Stefanie Sarantopoulos, William A. Wood, Paul Armistead, Don A. Gabriel, Jonathan S. Serody
2015 Biology of Blood and Marrow Transplantation  
Conclusion: In conclusion, although a similar rate of attrition was seen in donors overall, the reasons were different from our previous study. Two of the changes instituted are likely to have contributed (lowering joining age and increasing BMI). Further work must be done on understanding other factors associated with attrition, and collaborating with other international registries to permit access to donors who have moved to other countries.
doi:10.1016/j.bbmt.2014.11.494 fatcat:w4qina3u5bcu3by63dvs2pg62i